Wave-front Aberrometer Market - Growth, Trends, and Forecasts (2020 - 2025)
The wave-front aberrometer market is expected toregister a CAGR of XX% over the forecast period, due to the growing burden of eye diseases and technological advancements in the devices. According to the World Health Organization, about one billion people in 2019 suffered from blindness because of unaddressed refractive errors, near vision impairment, and presbyopia, globally. Uncorrected refractive errors are one of the major reasons for blindness. Hence, this factor augments the demand for novel diagnostic tools. This factor is expected to boost the demand for wave-front aberrometers.
Myopia Segment is Expected to Hold a Significant Market Share in the Wave-front Aberrometer Market
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the global wave-front aberrometer market, due to the high prevalence of eye-related diseases and the increasing aging population. According to the National Institute of Health, about millions of people in the United States are affected by one or the other eye condition and the aging population is at a greater risk. Furthermore, according to the Centre for Disease Control and Prevention, in 2017, around 8 million people in the United States were diagnosed with vision impairment because of refractive error. Hence, this factor is expected to boost the demand for wave-front aberrometers.
Companies are taking initiatives, such as launching new products to expand their presence in the market. For instance, in 2018, Essilor introduced a new product in the market, WAM700+ wave-front aberrometer. It is based upon Shack-Hartmann wavefront technology and fully-automated instrument. Some of the companies that are currently dominating the market are Novartis AG (Alcon), Carl Zeiss, Luneau Technology, Tracey Technologies, Essilor, Nidek Inc., Johnson & Johnson Visioncare Inc., SCHWIND eye-tech-solutions, Optikon, and Marco.